6 entries found
Sort by: Latest |Relevance
24 Sep 2018 description
report The Global Fund

In a high-security building in Kampala, Uganda, a man leads a group of sleuths investigating a potential killer. While they may go about their work with the meticulousness of police detectives, they are actually a different type of investigator. Professor Moses Joloba, Director of Uganda's Supranational Reference Laboratory, leads his team to pursue TB – the world’s leading killer among infectious diseases. The disease killed more than 1.6 million people around the world in 2017.

07 Aug 2015 description
report The Global Fund

Progress on Potential Malaria Vaccine

21 Oct 2011 description
report The Global Fund

Geneva – The Global Fund to Fight AIDS, Tuberculosis Malaria has invested $4.1 billion since 2002 to fight malaria, helping to save 830,000 lives by the end of 2010 through a dramatic increase in use of insecticide-treated nets and effective anti-malaria drugs in countries where the disease is endemic. An additional $2.18 billion in financing for malaria has been approved but not yet disbursed.

By mid-2011 results from programs that receive Global Fund support showed that 190 million insecticide-treated bed nets had been distributed to protect families from malaria.

14 Oct 2011 description

NAIROBI, Kenya, 14 October, 2011: An estimated two and a half million people in Somalia, already suffering from drought, famine and conflict, are at risk of contracting malaria with the start of the rainy season. To prevent a malaria epidemic and deaths, especially among malnourished young children and internally displaced populations, a massive response is underway. UNICEF, WHO and partners are scaling up the response to a potential malaria outbreak with funding from the Global Fund for AIDS, Tuberculosis and Malaria (GFATM) and the UK Department for International Development.

08 Jul 2009 description
report The Global Fund

88 Million Bed Nets Distributed for Malaria

Geneva - The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced that 2.3 million people living with HIV have been reached with lifesaving antiretroviral (ARV) treatment through AIDS programs it supports, a 31 per cent increase over results reported a year ago.

Global Fund-supported tuberculosis programs have so far put more than 5.4 million people on effective TB drugs treatment. Tuberculosis is the leading cause of death among HIV-infected people; the World Health Organization estimates that TB accounts for up to a …

01 Jun 2009 description
report The Global Fund

This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown of the results by country, and answers to commonly-asked questions.

Question 1: How many people are receiving ARVs from programs supported by Global Fund grants?

As of June 1st 2009, programs supported by the Global Fund have reported 2.3 million people currently on ARVs for treatment of HIV/AIDS.

Question 2: What is the regional breakdown of people currently receiving ARVs?